MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

T2 Biosystems Company Profile (NASDAQ:TTOO)

Consensus Ratings for T2 Biosystems (NASDAQ:TTOO) (?)
Ratings Breakdown: 4 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $12.93 (52.07% upside)

Analysts' Ratings History for T2 Biosystems (NASDAQ:TTOO)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016WBB SecuritiesUpgradeSpeculative Buy -> Buy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Cantor FitzgeraldReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Leerink SwannReiterated RatingOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/16/2016BTIG ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015Goldman SachsBoost Price TargetNeutral$13.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Jefferies GroupReiterated RatingBuy -> Fair Value$21.00 -> $11.48View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for T2 Biosystems (NASDAQ:TTOO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/2/2016Q1($0.54)($0.55)$1.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Q4($0.59)($0.56)$1.21 million$1.01 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q3($0.59)($0.57)$0.66 million$1.05 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.57)($0.54)$0.34 million$0.56 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.57)($0.53)$0.22 million$0.19 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414($0.44)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.58)($0.71)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for T2 Biosystems (NASDAQ:TTOO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.59)($0.55)($0.57)
Q2 20163($0.57)($0.54)($0.55)
Q3 20163($0.53)($0.52)($0.53)
Q4 20163($0.51)($0.46)($0.48)
(Data provided by Zacks Investment Research)
Dividend History for T2 Biosystems (NASDAQ:TTOO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for T2 Biosystems (NASDAQ:TTOO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/16/2016Rahul DhandaSVPSell7,588$8.01$60,779.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Aisling Capital Iii LpMajor ShareholderBuy307,692$9.75$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015David B ElsbreeDirectorBuy10,000$9.75$97,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2015Polaris Venture Partners V, L.Major ShareholderSell15,399$15.04$231,600.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.22$228,284.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.42$231,284.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.05$240,733.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.26$731,651.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$16.57$497,066.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.25$731,201.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Thomas J LoweryInsiderSell2,000$16.03$32,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$15.91$715,902.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.09$724,001.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.22$243,283.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.28$244,183.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$17.08$768,548.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$18.18$545,363.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$18.22$273,281.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Thomas J LoweryInsiderSell1,000$18.65$18,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Michael J CimaDirectorBuy1,000$18.91$18,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Thomas J LoweryInsiderSell1,471$18.55$27,287.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Michael A PfallerInsiderSell15,440$16.31$251,826.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Thomas J LoweryInsiderSell1,000$18.43$18,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015David B ElsbreeDirectorBuy1,450$15.05$21,822.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014David B ElsbreeDirectorBuy1,500$14.75$22,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Aisling Capital Iii LpMajor ShareholderBuy454,545$11.00$4,999,995.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Sarah O KalilCOOBuy15,000$11.00$165,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Thomas J CarellaDirectorBuy909,090$11.00$9,999,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for T2 Biosystems (NASDAQ:TTOO)
DateHeadline
06/26/16 07:55 AMT2 Biosystems Incorporated (NASDAQ:TTOO) Sellers Increased By 3.81% Their Shorts - Engelwood Daily
06/26/16 07:55 AMT2 Biosystems, Inc. (NASDAQ:TTOO) Earnings Glance and Target Price Review - Engelwood Daily
06/26/16 07:55 AMRecently Issued Stock Ratings For T2 Biosystems, Inc. (TTOO) - Fiscal Standard
06/26/16 07:55 AMWill T2 Biosystems, Inc. (NASDAQ:TTOO) Surprise Analysts? - Investor Newswire
06/24/16 09:30 AMAnalysts Upgrade of the Day: T2 Biosystems Inc (NASDAQ:TTOO)
06/23/16 07:42 PMAnalysts Upgrade of the Day: T2 Biosystems Inc (NASDAQ:TTOO) - iStreetWire
06/23/16 09:29 AMAnalyst Update: T2 Biosystems Inc, La Jolla Pharmaceutical Company, and Illumina, Inc. - Schaeffers Research (blog)
06/22/16 12:23 PMT2 BIOSYSTEMS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/21/16 06:26 PMT2 Biosystems (TTOO) Announces Presentation of Positive T2Candida Panel Data at ICAAC - StreetInsider.com
06/21/16 03:19 PMT2 Biosystems Announces New Data at ASM Microbe 2016 Demonstrating Benefits of Adopting T2Candida® Panel for Diagnosing Sepsis in Clinical Settings - [at noodls] - LEXINGTON, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida Panel ...
06/20/16 04:49 PMCantor Still Recommending A Buy For T2 BioSystems - Cantor Fitzgerald maintained its Buy rating on T2 Biosystems Inc (NASDAQ: TTOO) following the American Society for Microbiology (ASM) Microbe 2016 Conference. Moreover, the company reports that the T2Bacteria trial remains on track, which the brokerage believes may support T2Dx adoption in the second half of 2016, ahead of the anticipated T2Bacteria FDA clearance in early-2017. T2 provides Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, and serum. The company also offers T2Dx, a bench-top instrument ...Full story available on Benzinga.com
06/20/16 08:20 AMLeerink Partners Reiterates Outperform on T2 Biosystems (TTOO) - StreetInsider.com
06/13/16 06:27 PMT2 Biosystems, Inc. (NASDAQ:TTOO) Yearly Sales Estimate At $130.643 - Investor Newswire
06/09/16 06:13 PMT2 Biosystems Tackles Sepsis Testing -
06/08/16 10:04 AMT2 Biosystems Announces Presentations at ASM Microbe 2016 - GlobeNewswire (press release)
06/08/16 05:58 AMT2 Biosystems Announces Presentations at ASM Microbe 2016 - [at noodls] - LEXINGTON, Mass., June 08, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida Panel ...
06/03/16 09:59 AMShare Rating Focus on T2 Biosystems, Inc. (NASDAQ:TTOO) - HNN
06/02/16 07:29 PMStrong Sell Calls Count For T2 Biosystems, Inc. (NASDAQ:TTOO) At 0 - Investor Newswire - Strong Sell Calls Count For T2 Biosystems, Inc. (NASDAQ:TTOO) At 0Investor NewswireThe Sell calls on T2 Biosystems, Inc. (NASDAQ:TTOO) were 0. Two months earlier 3 were the Strong Buy calls whereas Strong Sell calls were 0. During this period, the hold calls were 2. The buy recommendations were 1 and sell calls count was 0. Analyst ...and more »
06/02/16 07:29 PMBroker Watchlist: T2 Biosystems, Inc. (TTOO) - Share Trading News - Broker Watchlist: T2 Biosystems, Inc. (TTOO)Share Trading News05/09/2015 – T2 Biosystems, Inc. was upgraded to “buy” by analysts at Janney Montgomery Scott. They now have a USD 25 price target on the stock. The share price of T2 Biosystems, Inc. (TTOO) was up +0.90% during the last trading session, with a day ...
06/02/16 10:12 AMT2 Biosystems (TTOO) Announces Publication of Positive T2Candida Panel Data - StreetInsider.com - T2 Biosystems (TTOO) Announces Publication of Positive T2Candida Panel DataStreetInsider.comT2 Biosystems, Inc. (Nasdaq: TTOO) announced that results from an investigational study evaluating its T2Candida Panel utilizing two mL of whole blood in pediatric patients was published in the American Journal of Clinical Pathology (AJCP). The data ...and more »
06/02/16 10:12 AMTarget Price and Stock Performance Rundown for T2 Biosystems, Inc. (NASDAQ:TTOO) - HNN - Target Price and Stock Performance Rundown for T2 Biosystems, Inc. (NASDAQ:TTOO)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, T2 Biosystems, Inc. (NASDAQ:TTOO) ...and more »
06/02/16 07:25 AMStudy Published in the American Journal of Clinical Pathology Demonstrates T2Candida Panel Provides Rapid and Accurate Diagnosis of Candida, a Leading Cause of Sepsis, in Pediatric Patients - [at noodls] - LEXINGTON, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that results from an ...
05/30/16 10:26 PMAfter Last Week What Do Analysts Think Of T2 Biosystems, Inc. (TTOO) - Share Trading News - After Last Week What Do Analysts Think Of T2 Biosystems, Inc. (TTOO)Share Trading News05/09/2015 – T2 Biosystems, Inc. was upgraded to “buy” by analysts at Janney Montgomery Scott. They now have a USD 25 price target on the stock. The share price of T2 Biosystems, Inc. (TTOO) was up +0.71% during the last trading session, with a day ...and more »
05/27/16 11:20 AMStock Rating Review for T2 Biosystems, Inc. (NASDAQ:TTOO) - Wall Street Hints and News - Stock Rating Review for T2 Biosystems, Inc. (NASDAQ:TTOO)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.83 on shares of T2 Biosystems, Inc. (NASDAQ:TTOO). Covering analysts ...and more »
05/26/16 10:22 AMT2 Biosystems, Inc. (NASDAQ:TTOO) EPS Estimate At $-0.53 - Investor Newswire - T2 Biosystems, Inc. (NASDAQ:TTOO) EPS Estimate At $-0.53Investor NewswireThe EPS projection of T2 Biosystems, Inc. (NASDAQ:TTOO) for quarter ended 2016-09-30 is $-0.53. A week earlier, the EPS target was $-0.53 against target of $-0.53, a month earlier. This target stood at $-0.53 60 days ago against estimate of $-0.53 90 ...
05/26/16 10:22 AMTarget Check and Stock Performance Recap T2 Biosystems, Inc. (NASDAQ:TTOO) - Wall Street Hints and News - Target Check and Stock Performance Recap T2 Biosystems, Inc. (NASDAQ:TTOO)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, T2 Biosystems, Inc.and more »
05/26/16 10:22 AMT2 Biosystems, Inc. (TTOO) Updated Broker Price Targets - Share Trading News - T2 Biosystems, Inc. (TTOO) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of T2 Biosystems, Inc. (TTOO). The latest reports which are currently in issue on Thursday 26th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...T2 Biosystems' COO Sarah Kalil Resigns (NASDAQ:TTOO)Sonoran Weekly ReviewT2 Biosystems (TTOO) COO Kalil ResignsStreetInsider.comall 3 news articles »
05/25/16 01:50 PMT2 BIOSYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers -
05/17/16 12:04 PMT2 BIOSYSTEMS, INC. Financials -
05/09/16 12:56 PMT2 BIOSYSTEMS, INC. Files SEC form 10-Q, Quarterly Report -
05/05/16 12:53 PMT2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/02/16 04:07 PMT2 Biosystems reports 1Q loss -
05/02/16 03:40 PMT2 Biosystems to Transition Chief Financial Officer Role to Shawn Lynch - [at noodls] - LEXINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that Chief Financial ...
05/02/16 03:10 PMT2 Biosystems Reports 2016 First Quarter Results - [at noodls] - LEXINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today reported operating highlights ...
05/02/16 06:07 AMQ1 2016 T2 Biosystems Inc Earnings Release - After Market Close -
04/27/16 06:01 AMT2 Biosystems to Present at Deutsche Bank Health Care Conference - [at noodls] - LEXINGTON, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Moe Castonguay, chief financial officer, ...
04/26/16 05:55 AMT2 Biosystems Announces 2016 First Quarter Results Release and Conference Call Date - [at noodls] - LEXINGTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 first quarter financial results after the market closes on Monday, May ...
03/15/16 02:02 PMWhat Is The ABR Of T2 Biosystems, Inc. (NASDAQ:TTOO)? - Investor Newswire - What Is The ABR Of T2 Biosystems, Inc. (NASDAQ:TTOO)?Investor NewswireZacks Research has reported T2 Biosystems, Inc. (NASDAQ:TTOO) to have ABR of 1.6. Investors always look out to invest in the companies that are considered as best performing in the industry. A group of investors acknowledges the value of research ...and more »
03/14/16 11:04 AMCan T2 Biosystems, Inc. (NASDAQ:TTOO) Earnings Impress Markets? - Stocks Daily - Can T2 Biosystems, Inc. (NASDAQ:TTOO) Earnings Impress Markets?Stocks DailyAs per Zacks Group, the key to lucrative investment is buying the premium stocks in the prominent industries. When stockholders understand the tangible meaning of earnings assessment, they intend to trail the ratings to recognize the best stocks ...T2 Biosystems Incorporated (NASDAQ:TTOO) Shorted Shares Increased By 18.63%SmallCapWired.comall 2 news articles »
03/09/16 02:03 PMT2 BIOSYSTEMS, INC. Files SEC form 10-K, Annual Report -
03/01/16 09:00 AMT2 Biosystems (Nasdaq: TTOO) to Ring The Nasdaq Stock Market Opening Bell - [GlobeNewswire] - T2 Biosystems, Inc., a company developing innovative diagnostic products to improve patient health, will visit the Nasdaq MarketSite in Times Square. Last month, the company announced that it met its goal ...
02/26/16 09:27 AMT2 Biosystems, Inc. (TTOO) Analyst Updates - Risers & Fallers - T2 Biosystems, Inc. (TTOO) Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of T2 Biosystems, Inc. (TTOO). According to the latest broker reports outstanding on Thursday 25th of February, 5 analysts have a rating of “strong buy”, 1 analysts “buy ...Were Analysts Bearish T2 Biosystems Inc (NASDAQ:TTOO) This Week?Business Standard Tribuneall 2 news articles »
02/18/16 01:53 PMT2 Biosystems Reports 2015 Fourth Quarter, Full Year Results - GlobeNewswire (press release) - T2 Biosystems Reports 2015 Fourth Quarter, Full Year ResultsGlobeNewswire (press release)LEXINGTON, Mass., Feb. 16, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today reported operating highlights and financial results for the fourth quarter and year ended December 31, 2015. Recent operational highlights included:.
02/18/16 11:38 AMT2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib -
02/18/16 09:21 AMT2 Biosystems, Inc. Earnings Analysis: 2015 By the Numbers -
02/16/16 07:06 PMEdited Transcript of TTOO earnings conference call or presentation 16-Feb-16 9:30pm GMT -
02/16/16 03:17 PMT2 Biosystems reports 4Q loss -
02/16/16 03:03 PM4:03 pm T2 Biosystems beats by $0.03, misses on revs -
02/16/16 03:00 PMT2 Biosystems Reports 2015 Fourth Quarter, Full Year Results - [GlobeNewswire] - LEXINGTON, Mass., Feb. 16, 2016-- T2 Biosystems, Inc. today reported operating highlights and financial results for the fourth quarter and year ended December 31, 2015. Recent operational highlights included:. ...
02/16/16 01:25 PMThe Profit of T2 Biosystems Inc (TTOO) Expected to Decrease - OctaFinance.com - The Profit of T2 Biosystems Inc (TTOO) Expected to DecreaseOctaFinance.comAnalysts await T2 Biosystems Inc (NASDAQ:TTOO) to reports earnings on February, 16. They expect $-0.61 earnings per share, down 35.56 % or $0.16 from last year's $-0.45 per share. After $-0.57 actual earnings per share reported by T2 Biosystems Inc for ...T2 Biosystems Inc (TTOO) to Release Earnings on TuesdayThe Vista VoiceStock to Watch For Earnings: T2 Biosystems Incorporated (TTOO)CWRU ObserverEPS for T2 Biosystems Inc (TTOO) to DecreaseWallStreet.orgIntercooler Financial -Street Edition -Uptick Analystall 9 news articles »
About T2 Biosystems

T2 Biosystems logoT2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TTOO
  • CUSIP:
Key Metrics:
  • Previous Close: $9.12
  • 50 Day Moving Average: $8.67
  • 200 Day Moving Average: $9.12
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $206.41M
  • Current Quarter EPS Consensus Estimate: $-2.17 EPS
Additional Links:
T2 Biosystems (NASDAQ:TTOO) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha